BUSINESS & SCIENTIFIC ADVISORS.
FOUNDING INVESTORS & ADVISORS
CO-FOUNDER & LIFE SCIENCE BUSINESS STRATEGY
Deployed >$1bn of capital into life science and healthcare ventures in his investor roles at Index, Medicxi, Bayer and Mubadala. Expert on drug discovery, cell & gene therapy and digital health ventures. Has been on both buy and sell sides of biotech-biopharma deals
co-founder & TECHNOLOGY BUSINESS STRATEGY
CEO of Curiosity, a group of proteomics-themed biotech companies backed by top investors. Founded companies with >$1bn in GMV and raised >$100m of capital. 12 years experience building high-growth businesses. Top global biohacking influencer
SCIENTIFIC ADVISORY BOARD
Dr. Angeli Möller
ROCHE PHARMACEUTICALS DIVISION, SWITZERLAND
Head of Pharma International Informatics
Alliance for Artificial Intelligence in Healthcare (AAIH) EXECUTIVE OFFICER & CO-FOUNDER
Prof. Manuel Mayr
British Heart Foundation Professor of Cardiovascular Proteomics
KING'S COLLEGE LONDON, UK
CHIEF SCIENTIFIC OFFICER
director of biology
Co-founder & CEO
30+ years in biopharma & healthcare, focusing on R&D management, B2B partnerships and value creation strategy. Has engaged with over 100 organizations in biopharma, medical technology and healthcare. Published authority on biopharma R&D partnerships and biotech business models
CHIEF SCIENCE & IP OFFICER
Forbes 30under30. Founded a cellular ageing biotech startup (The Longevity Labs GmbH, whose award-winning nutraceutical is now marketed in >14 countries incl. US), exited after 3 years. Operational leadership roles at two other data-intensive startups in cancer genomics and AI-enabled robotics respectively
CHIEF TECHNOLOGY & DATA OFFICER
Deep technical capabilities, strong academic network and author of multiple scientific papers on system biology modeling of cardiometabolic diseases. Most recent prior role was leading a data science team at a Boston-based biotech that was acquired for >$2 billion
Celia Antonio Schell
VP STUDY & PARTNERSHIP OPERATIONS
14 years experience in clinical research at Novartis and ICON (global CRO) including 10 years of managing international clinical studies. Most recent prior role was managing a global Phase III clinical study of >7,000 patients across 43 countries for a cardiovascular drug.
Lead DATA SCIENTIST
Accomplished systems biology modeler. Most recently at the European Bioinformatics Institute. Prior to this, conducted academic research and published on atherosclerosis modeling
CHIEF OF STAFF
Broad experience base in collaborative contexts. Product manager in a B2B financial data & solutions provider. Project manager in an energy & fintech business. Has founded and exited her own business
SCIENCE & PARTNERSHIP ANALYST
Analyst working at the cross-section of business and bioscience, with an MSc in Bioscience Entrepreneurship and a BSc in Biomedical Sciences. Prior experience includes working in bioscience SMEs across marketing and business development functions, as well as pharmaceutical R&D
BUSINESS & SCIENCE ANALYST
Analyst working across the bioscience and business interface with Master’s degree in Bioscience Entrepreneurship and Bachelor’s degree in biochemistry. Previous experience working in a range of healthcare-centred roles, spanning project support in primary care training to life sciences public relations
Want to be a part of our team?
Got a partnership in mind?
Get in touch with us and know more about how we are changing the face of healthcare.
Multiomic Health Limited is a registered UK company